The Food and Drug Administration yesterday announced a firmware update to reduce the risk of rapid battery depletion and address cybersecurity vulnerabilities in certain Abbott devices that provide pacing for slow heart rhythms and electrical shock or pacing to stop dangerously fast heart rhythms. The update applies to several families of Abbott (formerly St. Jude Medical) implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators, including certain devices included in a 2016 recall related to premature battery depletion. FDA recommends that all eligible patients receive the firmware update at their next regularly scheduled visit or when appropriate, depending on the preferences of the patient and physician. Firmware is a type of software embedded in the hardware of a medical device.

Related News Articles

Headline
The Health and Public Health Sector Coordinating Council, a public-private partnership, yesterday released a crisis response guide to help health care…
Headline
The Healthcare and Public Health Sector Coordinating Council, a public-private partnership developed to mitigate threats to the nation’s health care sector,…
Headline
China and its proxies have been observed attempting to identify and illicitly obtain valuable intellectual property and public health data related to vaccines…
Headline
The Department of Homeland Security and the Cybersecurity and Infrastructure Security Agency have updated their telework guidance to include new guidance on…
Headline
Cyber actors have launched phishing campaigns against first responders, initiated denial-of-service assaults against government agencies and threatened medical…
Headline
The FBI warned today of specific COVID-19-themed email phishing campaigns targeting U.S.-based medical providers. The campaigns leverage email subject lines…